Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP2QZ
|
||||
Drug Name |
3-(3-(1H-imidazol-1-yl)propyl)-1-(3-bromobenzyl)-5-methyl-5-(naphthalen-1-yl)imidazolidine-2,4-dione
|
||||
Synonyms |
CHEMBL204674
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H25BrN4O2
|
||||
Canonical SMILES |
CC1(N(Cc2cccc(Br)c2)C(=O)N(CCCn3ccnc3)C1=O)c4cccc5ccccc45
|
||||
InChI |
InChI=1S/C27H25BrN4O2/c1-27(24-12-5-9-21-8-2-3-11-23(21)24)25(33)31(15-6-14-30-16-13-29-19-30)26(34)32(27)18-20-7-4-10-22(28)17-20/h2-5,7-13,16-17,19H,6,14-15,18H2,1H3
|
||||
InChIKey |
DIBXXBYKQOAPHR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.